SK Chemicals Launches High-Dose 300 mg Joins for Osteoarthritis Treatment
SK Chemicals has announced the release of a new high-dose version of Joins, its flagship natural product-based medication for osteoarthritis.
Biowatch
Daewoong Pharmaceutical: Record "Nabota" Sales Clouded by Looming Legal Risks
As Daewoong Pharmaceutical celebrates record-breaking financial results driven by its flagship botulinum toxin, Nabota, a shadow remains over its...
Datroway Approved: New Targeted Therapy Offers Hope for Metastatic Breast Cancer
A new therapeutic horizon has arrived for patients battling metastatic breast cancer that has progressed despite...
Daewoong Pharmaceutical’s ‘Ursa’ Shows Symptom Improvement in Early Post-COVID Patients
Daewoong Pharmaceutical announced on the 9th that Ursodeoxycholic Acid , the primary ingredient in its flagship product...
Korean Biotech Firms Join Forces to Uncover the Hidden Profiles of Cancer Cells
Even within a single tumor, cancer cells present many different "faces." While they may appear as a uniform mass, every...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR
Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum
Alteogen is set to accelerate its financial growth this year, driven by a surge in milestone payments and royalty...
FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate
Abl Bio announced on March 3rd that the U.S. Food and Drug Administration has approved the Investigational New Drug...
SK Bioscience Secures First EU-Led Vaccine Project in Landmark Triple Consortium
SK Bioscience announced on February 26th that a tripartite consortium including the company has been selected for the...
Is Your 'Focus Supplement' a Warning Sign? High Tyrosine Levels Linked to Shorter Lifespan in Men
Tyrosine, an amino acid widely marketed as a cognitive enhancer to sharpen focus, may be linked to a significant...